In patients with type 2 diabetes (T2D) inadequately controlled on metformin, semaglutide may have a greater impact than canagliflozin in reducing HbA1c levels and bodyweight, according to the phase IIIb SUSTAIN 8* trial presented at EASD 2019.
The LITE (Lifestyle Intervention for Teenagers) programme, a family-based behavioural lifestyle intervention, demonstrates acceptability, feasibility as well as short-term clinical effectiveness in improving some clinical outcomes and adolescents’ perception of family support, according to a Singapore study.
Diets with low glycaemic index (GI) appear to be beneficial for glycaemic control and may even reduce body weight in people with prediabetes or diabetes, according to the results of a systematic review and meta-analysis.
Subgroup analyses of the GLOBAL LEADERS study showed similar treatment effects between ticagrelor and aspirin monotherapy following percutaneous coronary intervention (PCI) in patients with impaired renal function (IRF)* and diabetes.
Almost half of Asian patients with dyslipidaemia and hypertension, as well as half of those on pharmacotherapy, have achieved their blood pressure (BP) treatment goals, a Singapore study has shown. Moreover, BP goal attainment is significantly associated with type 2 diabetes mellitus (T2DM) and low-density lipoprotein (LDL-C) control.